380 related articles for article (PubMed ID: 35198442)
1. Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment.
Yu S; Wang Y; He P; Shao B; Liu F; Xiang Z; Yang T; Zeng Y; He T; Ma J; Wang X; Liu L
Front Oncol; 2022; 12():809304. PubMed ID: 35198442
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy and immunotherapy: what is the optimal timing or sequencing?
Aliru ML; Schoenhals JE; Venkatesulu BP; Anderson CC; Barsoumian HB; Younes AI; K Mahadevan LS; Soeung M; Aziz KE; Welsh JW; Krishnan S
Immunotherapy; 2018 Feb; 10(4):299-316. PubMed ID: 29421979
[TBL] [Abstract][Full Text] [Related]
3. Nanomaterials as Smart Immunomodulator Delivery System for Enhanced Cancer Therapy.
Yuan C; Liu Y; Wang T; Sun M; Chen X
ACS Biomater Sci Eng; 2020 Sep; 6(9):4774-4798. PubMed ID: 33455212
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapies catering to the unmet medical need of cold colorectal cancer.
Yuan J; Li J; Gao C; Jiang C; Xiang Z; Wu J
Front Immunol; 2022; 13():1022190. PubMed ID: 36275766
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy.
Fan Y; Moon JJ
Vaccines (Basel); 2015 Aug; 3(3):662-85. PubMed ID: 26350600
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
Yang J; Zhang C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
[TBL] [Abstract][Full Text] [Related]
7. Advances of Nanomedicine in Radiotherapy.
Liu W; Chen B; Zheng H; Xing Y; Chen G; Zhou P; Qian L; Min Y
Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834172
[TBL] [Abstract][Full Text] [Related]
8. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
Madden DL
Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
[TBL] [Abstract][Full Text] [Related]
9. Novel insight into the role of immunotherapy in gastrointestinal cancer (Review).
Liu Y; Chen J; Xu Y; Sun Q
Mol Clin Oncol; 2022 Dec; 17(6):157. PubMed ID: 36338605
[TBL] [Abstract][Full Text] [Related]
10. Nanomaterials for cancer immunotherapy.
Song W; Musetti SN; Huang L
Biomaterials; 2017 Dec; 148():16-30. PubMed ID: 28961532
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy and immunotherapy: a synergistic effect in cancer care.
Turgeon GA; Weickhardt A; Azad AA; Solomon B; Siva S
Med J Aust; 2019 Jan; 210(1):47-53. PubMed ID: 30636308
[TBL] [Abstract][Full Text] [Related]
12. Adapting conventional cancer treatment for immunotherapy.
Qiao J; Liu Z; Fu YX
J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
[TBL] [Abstract][Full Text] [Related]
13. Nanodrug Delivery Systems in Antitumor Immunotherapy.
Guo Z; Ye J; Cheng X; Wang T; Zhang Y; Yang K; Du S; Li P
Biomater Res; 2024; 28():0015. PubMed ID: 38840653
[TBL] [Abstract][Full Text] [Related]
14. The Angiopoietin-2 and TIE Pathway as a Therapeutic Target for Enhancing Antiangiogenic Therapy and Immunotherapy in Patients with Advanced Cancer.
Leong A; Kim M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33217955
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies.
Chyuan IT; Chu CL; Hsu PN
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801815
[TBL] [Abstract][Full Text] [Related]
16. Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives.
Mortezaee K; Najafi M
Crit Rev Oncol Hematol; 2021 Jan; 157():103180. PubMed ID: 33264717
[TBL] [Abstract][Full Text] [Related]
17. Light-activated nanomaterials for tumor immunotherapy.
Wang F; Duan H; Xu W; Sheng G; Sun Z; Chu H
Front Chem; 2022; 10():1031811. PubMed ID: 36277335
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy.
Yu WD; Sun G; Li J; Xu J; Wang X
Cancer Lett; 2019 Jun; 452():66-70. PubMed ID: 30902563
[TBL] [Abstract][Full Text] [Related]
19. Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy.
Chen Z; Yue Z; Yang K; Shen C; Cheng Z; Zhou X; Li S
Adv Healthc Mater; 2023 Oct; 12(26):e2300882. PubMed ID: 37539730
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
